European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Tenders

Blood products tenders in Romania

Blood products tenders in Romania: 6,702 listed on GranTender since 2024. Buyers with the most tenders: Spitalul Judetean Satu Mare (286), Spitalul Judetean de Urgenta Bacau (203) and Spitalul Judetean de Urgenta Zalau (175); suppliers with the most contract awards: FARMEXIM S.A. (1,579), Alliance Healthcare Romania (1,125) and DR.MAX (983). Sources: SEAP / SICAP and TED. In 2025, 21% of contracts drew a single bid (3.6 bids on average). Data as of 17 November 2026; updated daily.

Tenders
6,702
Open tenders
0
Awards
14,174
Awarded value awarded
€172,950,153
Awarded value contract
€13,642,990
Awarded value framework ceiling
€623,822,538
Median contract value awarded
≈ €410
Median contract value framework ceiling
≈ €2,400
Median contract value contract
≈ €1,900
Average bids per contract
3.5
Tenders in 2025
2,470 -10% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

No records yet.

Latest tenders

TenderBuyerEstimated valueStatusPublished
acord cadru de furnizare medicamente din grupa ; "imunoglobuline- imunoglobulina anti D 300mcg/2ml "Spitalul Clinic Judetean MuresRON 112,720 (≈ €21,416)Closed19 October 2026
MEDICAMENTE - IMUNOGLOBULINA UMANA NORMALACentrul National Clinic de Recuperare Neuropsihomotorie Copii Dr. Nicolae RobanescuRON 3,758,188 (≈ €714,036)Closed24 June 2026
MEDICAMENTE - IMUNOGLOBULINA UMANA NORMALACentrul National Clinic de Recuperare Neuropsihomotorie Copii Dr. Nicolae RobanescuRON 3,758,189 (≈ €714,037)Awarded24 June 2026
Acord cadru de furnizare imunoglobulineSpitalul Clinic Judetean de Urgenta Targu.MuresRON 13,850,240 (≈ €2,631,475)Awarded8 June 2026
Acord cadru de furnizare imunoglobulineSpitalul Clinic Judetean de Urgenta Targu.MuresRON 13,850,240 (≈ €2,631,475)Closed8 June 2026
achizitie medicamente 2-2026Spitalul Clinic Dr. I. CantacuzinoRON 25,345,377 (≈ €4,815,492)Awarded28 April 2026
acord cadru de furnizare medicamente din grupa - Imunoglobuline 2 loturiSpitalul Clinic Judetean MuresRON 552,101 (≈ €104,896)Closed23 April 2026
Antineoplazice, Imunoglobuline, Antihemoragice, Preparate impotriva anemiei, Diverse medicamente - 58 loturi 1-2026Spitalul Clinic de Urgenta pentru Copii Cluj-NapocaRON 5,792,865 (≈ €1,100,615)Awarded21 April 2026
ACORD CADRU DE FURNIZARE CONSUMABILE MEDICALE PENTRU BANCA DE CELULE, 48 de luniInstitutul Regional de Oncologie IasiRON 4,574,794 (≈ €869,187)Awarded21 April 2026
ACORD CADRU DE FURNIZARE CONSUMABILE MEDICALE PENTRU BANCA DE CELULE, 48 de luniInstitutul Regional de Oncologie IasiRON 4,574,793 (≈ €869,187)Closed21 April 2026
ACHIZITIONARE DE ALBUMINUM HUMANUM SI FIBRINOGEN UMANSpitalul Clinic de Urgenta Chirurgie Plastica Reparatorie si Arsuri BucurestiRON 3,772,500 (≈ €716,756)Awarded16 April 2026
ACHIZITIONARE DE ALBUMINUM HUMANUM SI FIBRINOGEN UMANSpitalul Clinic de Urgenta Chirurgie Plastica Reparatorie si Arsuri BucurestiRON 3,772,500 (≈ €716,756)Closed16 April 2026
FURNIZARE MEDICAMENTE PENTRU PROGRAMUL NATIONAL DE TRATAMENT PENTRU BOLI RARE – SUBPROGRAM BOLI NEUROLOGICE DEGENERATIVE/INFLAMATORII CRONICESpitalul Clinic de Recuperare IasiRON 396,027,913 (≈ €75,243,272)Closed8 April 2026
FURNIZARE MEDICAMENTE PENTRU PROGRAMUL NATIONAL DE TRATAMENT PENTRU BOLI RARE – SUBPROGRAM BOLI NEUROLOGICE DEGENERATIVE/INFLAMATORII CRONICESpitalul Clinic de Recuperare IasiRON 396,027,914 (≈ €75,243,272)Awarded8 April 2026
IMMUNOCARD (CF 148) – C4: Materiale, reactivi, consumabile și alte produse similare necesare pentru cercetare fundamentală de înaltă performanță, in cadrul ProiectuluiInstitutul de Biologie si Patologie Celulara '' Nicolae Simionescu''RON 104,645 (≈ €19,882)Closed2 April 2026
IMMUNOCARD (CF 148) – C4: Materiale, reactivi, consumabile și alte produse similare necesare pentru cercetare fundamentală de înaltă performanță, in cadrul ProiectuluiInstitutul de Biologie si Patologie Celulara '' Nicolae Simionescu''RON 104,646 (≈ €19,882)Awarded2 April 2026
THERAGENLIV (CF 197) – C.4: Materiale, reactivi, consumabile și alte produse similare necesare pentru cercetare fundamentală de înaltă performanță în cadrul ProiectuluiInstitutul de Biologie si Patologie Celulara '' Nicolae Simionescu''RON 66,301 (≈ €12,597)Closed26 March 2026
Furnizare produse medicamentoaseSpitalul Clinic de Pediatrie SibiuRON 23,565,831 (≈ €4,477,387)Awarded26 March 2026
THERAGENLIV (CF 197) – C.4: Materiale, reactivi, consumabile și alte produse similare necesare pentru cercetare fundamentală de înaltă performanță în cadrul ProiectuluiInstitutul de Biologie si Patologie Celulara '' Nicolae Simionescu''RON 66,301 (≈ €12,597)Awarded26 March 2026
Acord-cadru de furnizare Medicamente pentru Boli Rare -Boli Neurologice degenerative/inflamator-imune, forme acute si forme croniceSpitalul Clinic Municipal Cluj-NapocaRON 3,154,631 (≈ €599,364)Awarded3 February 2026

Competition and prices

In 2025, contracts drew 3.6 bids on average (median 3) and 21% drew a single bid — based on 1,263 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 15% and the share of single-bid contracts fell from 28% to 21%. The usual procedures: open procedure (96%), negotiation without a call for competition (4%) — of 79 tenders with a stated procedure.

The most contracts went to FARMEXIM S.A. (1,579), Alliance Healthcare Romania (1,125) and DR.MAX (983) — together 26% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
20244,379€340€100 – €1,4003.428% (1,331)
20253,891€390€120 – €1,5003.621% (1,263)
2026 (so far)3,652€520€150 – €2,2003.623% (2,188)
All years14,174€410€120 – €1,5003.523% (5,437)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 22% of the 3,906 contracts with a known number of bids had a single bid; the median was 4 bids. The number of bids is known for 3,906 of the 8,440 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

In the last 12 months, 0 companies won their first contract in our records here — 0% of the 4,216 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33141500 Haematological consumables
  • 33651500 Immune sera and immunoglobulins

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Blood products and immunoglobulins in neighbouring countries

Today, 2 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. In countries outside the EU and the EEA, the notice says who may bid. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon5

ExpectedBuyerWhatWhy we expect itConfidence
now – Dec 2026
every year
Spitalul Clinic Judetean de Urgenta Targu.MuresBlood products and immunoglobulins
Acord cadru de furnizare imunoglobuline
The buyer has published blood products tenders every year in November since 2024.
Earlier tenders: 12/2025, 11/2024
medium
now – Jan 2027
contract ends
Spitalul Municipal Odorheiu SecuiescBlood products and immunoglobulins
Acord-cadru de furnizare medicamente din Programul Național HEMOFILIE si TALASEMIE, cod P2.2024, pe o perioadă de 24 de luni
Typical value: ≈ €830,000
The current contract with FILDAS TRADING ends on 31 January 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 12/2024
high
now – Jan 2027
contract ends
Institutul Clinic FundeniBlood products and immunoglobulins
Imunoglobulina;Albumina
Typical value: ≈ €13m
The current contract with Prisum HEALTHCARE S.R.L. ends on 6 February 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 03/2024
medium
Feb – May 2027
every year
Institutul de Biologie si Patologie Celulara '' Nicolae Simionescu''Blood products and immunoglobulins
THERAGENLIV (CF 197) – C.4: Materiale, reactivi, consumabile și alte produse similare necesare pentru cercetare fundamentală de înaltă performanță în cadrul Proiectului
Typical value: ≈ €80,000
The buyer has published blood products tenders every year in April since 2024.
Earlier tenders: 03/2026, 05/2025, 03/2024
medium
Mar – Aug 2027
contract ends
Spitalul Municipal Campulung MuscelBlood products and immunoglobulins
MEDICAMENTE : SOLUTII INJECTABILE - CPV : 33692500-2; MEDICAMENTE PT. SISTEMUL GENITO - URINAR SI HORMONI - CPV 33640000-8; SOLUTII PENTRU PERFUZII - CPV 33692400-1; VACINURI - CPV: 33651600-4 ; ALBUMINA - CPV: 33141540-7; HEPARINUM - CPV 33141550-0; MEDICAMENTE PT SANGE, PT ORGANELE HEMATOPOIETICE SI SIST. CARDIOVASCULAR - CPV 3362000-2; ANTIINFECTIOASE GENERALE PENTRU UZ SISTEMIC - CPV 336
Typical value: ≈ €80,000
The current contract with ALLIANCE HEALTHCARE ROMANIA ends on 26 September 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 07/2025
medium

Forecast from public data, not an announcement. Methodology.

Market reports

Blood products and immunoglobulins by city

Blood products and immunoglobulins in other countries

Blood products and immunoglobulins across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Where can I find blood products tenders in Romania?
GranTender lists them in one place, from SEAP / SICAP and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most blood products tenders in Romania?
By number of contracts won: FARMEXIM S.A. (1,579), Alliance Healthcare Romania (1,125), DR.MAX (983).
Which buyers publish the most blood products tenders in Romania?
By number of tenders: Spitalul Judetean Satu Mare (286), Spitalul Judetean de Urgenta Bacau (203), Spitalul Judetean de Urgenta Zalau (175).
Which CPV codes belong to “Blood products and immunoglobulins”?
33141500 Haematological consumables; 33651500 Immune sera and immunoglobulins; plus tenders without a usable CPV code whose title names the topic.
How many bids do blood products tenders in Romania receive on average?
In 2025, contracts drew 3.6 bids on average (median 3) and 21% drew a single bid — based on 1,263 contracts with a known number of bids.
Which procedures are used for blood products tenders in Romania?
The usual procedures: open procedure (96%), negotiation without a call for competition (4%) — of 79 tenders with a stated procedure.
Which buyers get few offers in blood products tenders in Romania?
Since 1 November 2024, these buyers usually received one or two offers per contract: Institutul de Biologie si Patologie Celulara '' Nicolae Simionescu'' (median 1 bid over 99 contracts) and Institutul Regional de Oncologie Iasi (median 1 bid over 8 contracts). Since 1 November 2024, 22% of the 3,906 contracts with a known number of bids had a single bid; the median was 4 bids.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.